Chile vs Thailand: Cause of death, by non-communicable diseases, ages 15-59
Chile
58.2%
in 2021
Thailand
58.9%
in 2021
Chile rank
80th
Thailand rank
77th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Chile
- Thailand
How they compare
Thailand currently reports 58.9% against 58.2% in Chile, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Chile ahead.
Chile ranks 80th and Thailand ranks 77th of 185 countries.
Across the 3 decades both report, Chile averaged higher in 2 and Thailand in 1.
Head to head by decade
| Decade | Chile | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.5% | 36.3% | 27.3% | Chile |
| 2010s | 68.5% | 53.7% | 14.7% | Chile |
| 2020s | 59.7% | 60.1% | 0.4% | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Chile or Thailand?
- Thailand, at 58.9% against 58.2% in Chile as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Chile and Thailand?
- 0.7%, with Thailand ahead.
- How many years of comparable data are there for Chile and Thailand?
- 6 years are reported by both, from 2000 to 2021.
- How do Chile and Thailand rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Chile ranks 80th and Thailand ranks 77th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.